DOVER, N.H., Nov. 4 /PRNewswire/ -- TissueLink Medical, Inc. announced today that it had received the Nixon Peabody/Smith & Nephew Medical Device Innovation Award in the Early Stage Company Category from the Massachusetts Medical Device Industry Council (MassMEDIC) for the Aquamantys System. The award was presented to the company during MassMEDIC’s Annual MedTech Investors Conference held in Boston on November 1, 2005.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000508/TISSUELINKLOGO )
TissueLink Medical was granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Aquamantys(TM) System on October 25, 2005. This System is designed to seal blood vessels in soft tissue and bone during a wide variety of surgical procedures in order to reduce blood loss and the risk of transfusion. The Aquamantys System works by combining a bipolar electrosurgical generator with a rotary peristaltic pump to provide simultaneous delivery of radio-frequency energy and saline when used with Aquamantys hand-held disposable devices. The saline cools the tissue as it is treated and evenly conducts the energy into the tissue to seal blood vessels.
“We are very pleased that MassMEDIC has honored us with this award,” stated Jacqueline Eastwood, TissueLink’s President and Chief Executive Officer. “This award recognizes the efforts of the employees of TissueLink Medical to develop innovative devices which are designed to assist surgeons to reduce surgical blood loss and its associated intra- and post-operative complications while also helping to improve patient outcomes.”
About MassMEDIC
The Massachusetts Medical Device Industry Council (MassMEDIC) was established in 1996 by medical device company executives interested in promoting the unique interests of the Bay State’s vibrant medical technology sector. MassMEDIC now has over 300 members -- manufacturers, product developers, suppliers, research institutions and academic health centers. We advocate industry positions at the federal and state government levels, and conducts numerous informational seminars, conferences and issue briefings aimed at bringing the region’s medical device community the latest and best information on policies and trends impacting the sector.
About TissueLink Medical
TissueLink Medical, Inc., develops and markets innovative products that simplify surgery and improve patient outcomes. The company’s patented saline- enhanced radiofrequency platform technology is designed to reduce or eliminate bleeding during a wide variety of surgical procedures.
For more information on TissueLink Medical, visit the company website at http://www.tissuelink.com
Contact information: Joseph Army Vice-President of Finance and Chief Financial Officer TissueLink Medical, Inc. One Washington Center, Suite 400 Dover, NH 03820 Tel: (603)742-1515 Fax: (603)742-1488 E-mail: jarmy@tissuelink.com
Photo: http://www.newscom.com/cgi-bin/prnh/20000508/TISSUELINKLOGOAP Archive: http:TissueLink Medical, Inc.
CONTACT: Joseph Army, Vice-President of Finance and Chief FinancialOfficer of TissueLink Medical, Inc., +1-603-742-1515, jarmy@tissuelink.com
Web site: http://www.tissuelink.com//
